Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-22

FDA Approved: SOTYLIZE — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved SOTYLIZE (sotalol hydrochloride) through an Original NDA from Azurity Pharmaceuticals for antiarrhythmic use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOTYLIZE (Sotalol hydrochloride)

Snippet

ORIG AP for SOTYLIZE (SOTALOL HYDROCHLORIDE)